Literature DB >> 2188868

Escherichia coli O157:H7-associated colitis. A clinical and histological study of 11 cases.

P M Griffin1, L C Olmstead, R E Petras.   

Abstract

Hemorrhagic colitis is characterized by abdominal cramps, bloody diarrhea, and no or low-grade fever. Most cases are caused by the Shiga-like toxin-producing bacteria, Escherichia coli O157:H7. Nineteen colonic biopsy specimens and one resection specimen were reviewed from 11 patients with E. coli O157:H7-associated colitis to determine whether histologic features could be useful in diagnosis or in suggesting pathogenesis. All specimens showed hemorrhage and edema in the lamina propria. Specimens from nine patients were focally necrotic and showed hemorrhage and acute inflammation in the superficial mucosa with preservation of the deep crypts, similar to the pattern of injury associated with acute ischemic colitis. Specimens from five patients showed neutrophils focally infiltrating the lamina propria and crypts, resembling the pattern of injury seen in infectious colitis. One or both of these histologic patterns were observed in specimens from all but one patient. Specimens from four patients had poorly formed inflammatory pseudomembranes. It is concluded that the histologic features of E. coli O157:H7-associated colitis resemble a combination of ischemic and infectious injuries similar to those described in toxin-mediated Clostridium difficile-associated colitis. This suggests that the toxin(s) produced by these E. coliplay a role in the colonic injury. Infection with E. coli O157:H7 should be considered in the differential diagnosis of ischemic and infectious colitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2188868     DOI: 10.1016/0016-5085(90)91241-w

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  40 in total

Review 1.  [Bacterial colitis].

Authors:  G B Baretton; D E Aust
Journal:  Pathologe       Date:  2011-09       Impact factor: 1.011

2.  Pancreatitis and E. coli O157:H7 colitis without hemolytic uremic syndrome.

Authors:  David A Sass; Kapil B Chopra; Miguel D Regueiro
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

Review 3.  Biopsy interpretation of colonic biopsies when inflammatory bowel disease is excluded.

Authors:  Tze S Khor; Hiroshi Fujita; Koji Nagata; Michio Shimizu; Gregory Y Lauwers
Journal:  J Gastroenterol       Date:  2012-02-10       Impact factor: 7.527

4.  Verocytotoxin producing Escherichia coli.

Authors:  M G Brook; B A Bannister
Journal:  BMJ       Date:  1991-10-05

Review 5.  Escherichia coli O157:H7--two case reports.

Authors:  J M Lee; B Crowley; P A Cahill; D S O'Briain; C Keane; D G Gill; C A O'Morain
Journal:  Ir J Med Sci       Date:  1997 Jan-Mar       Impact factor: 1.568

6.  Shiga toxin-producing Escherichia coli can impair T84 cell structure and function without inducing attaching/effacing lesions.

Authors:  Z Li; E Elliott; J Payne; J Isaacs; P Gunning; E V O'loughlin
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

7.  Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration.

Authors:  B P Hurley; C M Thorpe; D W Acheson
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

8.  Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression.

Authors:  C M Thorpe; W E Smith; B P Hurley; D W Acheson
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

9.  Critical roles for stx2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits.

Authors:  Jennifer M Ritchie; Cheleste M Thorpe; Arlin B Rogers; Matthew K Waldor
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

10.  Nonpathogenic Escherichia coli can contribute to the production of Shiga toxin.

Authors:  Shantini D Gamage; Jane E Strasser; Claudia L Chalk; Alison A Weiss
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.